26/03/2018 - Research

Two new papers describe more about the relationship between cancer cells and the immune system

The Innate Immunity Group, led by Maria Rosa Sarrias has published two papers on their work on how cancer cells subtly retrain the body's immune system and subvert its natural defences.  In this case the group has worked on liver cancer, in conjunction with the Childhood Liver Cancer Group (C-Log), Marga Sala (Hepatology Unit, Department of Gastroenterology, Germans Trias Hospital) and doctors from a large number of hospitals, but they believe the mechanism may be important for the prognosis of many different cancers.

22/03/2018 - Research

Telomere shortening is not a factor in the progression of cardiac insufficiency

Researchers from the Heart Disease Research Group at the Germans Trias I Pujol Research Institute (IGTP) and researchers from the Spanish Biomedical Research Network for Cardiovascular Disease (CIBERCV) have analysed  the degree of shortening of telomeres and its correlation with  progression of cardiac insufficiency (CI) over a year. The results published in Journal of Translational Medicine indicate that telomere shortening in monocytes is probably not a biomarker for the progression of CI

16/03/2018 - Research

A proteomic study takes a step towards new biomarkers for dilated cardiomyopathy

Researchers from the IGTP carry out the first proteomic profiling for extracellular vesicles in patients with dilated cardiomyopathy

13/03/2018 - Research

Supervised exercise regimes drastically reduce symptoms for McArdle’s disease patients

The Neuromuscular and Neuropaediatrics Research Group at the IGTP particpates in the largest study of McArdle’s disease patients carried out in Spain.  The study, published in BMC Genomics, concluded that the best therapy is to adopt a supervised exercise regime.

05/03/2018 - Campus Can Ruti, Research

Reusable water bottles in an appeal coinciding with World Kidney Day

Today and during all of this week reusable water bottles will be on sale at three supermarkets of the Sorli chain in Badalona.  Funds from the sales will support research into kidney disease.   The event is part of the celebration of World Kidney Day, which takes place on 8 March.

15/02/2018 - Research

IGTP researchers confirm the feasibility of immunotherapy in cells of the immune system of patients with type 1 diabetes

Researchers from the Immunology of Diabetes research group of the Germans Trias i Pujol Research Institute (IGTP) have confirmed, in human cells, that liposomes designed as immunotherapy for type 1 diabetes (T1D) are a valid strategy to arrest the autoimmune attack characteristic of this disease. They have done so in a preclinical study demonstrating the tolerogenic effect of these liposomes on cells of the immune system of patients with T1D. The results have been published in the journal Frontiers in Immunology.

09/02/2018 - Campus Can Ruti, Research

Julia García Prado, new IGTP Scientific Director

Dr. García Prado, leader of the Viral Immune Evasion and Vacciones (VIRIEVAC) at the IrsiCaixa AIDS Research Institute will combine the new position with the leadership of her group, focused on the design of new strategies against HIV. Manel Puig, General Director of the IGTP, has presented the new organizational chart during the presentation of the Research Agenda 2018, together with the new challenges for the coming years.

06/02/2018 - Campus Can Ruti, Research

Vote for Dr. Vavouri in the Vanguardia de la Ciencia award

Tanya Vavouri, researcher at the IGTP and Josep Carreras Leukemia Research Institute is one of the nominees for the Vanguardia de la Ciencia award, for the study showing that environment affects genetics and can be retained for generations. The vote is open to everyone, scientist or not, until February 28. 

31/01/2018 - Research

The IGTP leads the biological and pathological studies in an international clinical trial focused on child and adolescent liver tumours

It is the first and largest international clinical trial ever in this type of patients. IGTP researchers coordinate what is going to be a unique collection in Europe of biological samples for this segment of patients, and will lead the posterior studies. Liver cancer in children is classified as a rare diseases and, in Spain, 15 cases are diagnoses every year.

23/01/2018 - Research

The new Spin-off Ahead Therapeutics SL, will develop new therapies for auto-immune diseases

The spin-off is the result of a joint research project between the IGTP, ICN2 and ICREA and has already attracted 1.1 million euros. The Catalan biotech company has been created to develop the therapies for clinical use. The therapy uses liposomes to halt the destructive reaction of the body's own tissues caused by diseases such as Type 1 diabetes or multiple sclerosis.